DD158856A5 - Verfahren fuer die herstellung einer mischung eines antiinflammotorischen steroids und eines als propellant verwendeten fluorchlor-kohlenwasserstoffes - Google Patents

Verfahren fuer die herstellung einer mischung eines antiinflammotorischen steroids und eines als propellant verwendeten fluorchlor-kohlenwasserstoffes Download PDF

Info

Publication number
DD158856A5
DD158856A5 DD81230036A DD23003681A DD158856A5 DD 158856 A5 DD158856 A5 DD 158856A5 DD 81230036 A DD81230036 A DD 81230036A DD 23003681 A DD23003681 A DD 23003681A DD 158856 A5 DD158856 A5 DD 158856A5
Authority
DD
German Democratic Republic
Prior art keywords
steroid
propellant
mixture
particle size
temperature
Prior art date
Application number
DD81230036A
Other languages
German (de)
English (en)
Inventor
Paavo T Tanskanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DD158856A5 publication Critical patent/DD158856A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD81230036A 1980-05-19 1981-05-18 Verfahren fuer die herstellung einer mischung eines antiinflammotorischen steroids und eines als propellant verwendeten fluorchlor-kohlenwasserstoffes DD158856A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI801610A FI63672C (fi) 1980-05-19 1980-05-19 Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan

Publications (1)

Publication Number Publication Date
DD158856A5 true DD158856A5 (de) 1983-02-09

Family

ID=8513487

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81230036A DD158856A5 (de) 1980-05-19 1981-05-18 Verfahren fuer die herstellung einer mischung eines antiinflammotorischen steroids und eines als propellant verwendeten fluorchlor-kohlenwasserstoffes

Country Status (21)

Country Link
US (1) US4347236A (es)
JP (1) JPS5716820A (es)
AT (1) AT380791B (es)
BE (1) BE888822A (es)
CA (1) CA1162852A (es)
CH (1) CH647408A5 (es)
CS (1) CS221831B2 (es)
DD (1) DD158856A5 (es)
DE (1) DE3119745A1 (es)
DK (1) DK218481A (es)
ES (1) ES8203606A1 (es)
FI (1) FI63672C (es)
FR (1) FR2482457A1 (es)
GB (1) GB2076422B (es)
HU (1) HU188093B (es)
NL (1) NL8102457A (es)
NO (1) NO155429C (es)
PL (1) PL127872B1 (es)
PT (1) PT72989B (es)
SE (1) SE437766B (es)
SU (1) SU1184428A3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
AU601176B2 (en) * 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
JPH01156916A (ja) * 1987-09-25 1989-06-20 Ss Pharmaceut Co Ltd 肝疾患治療剤
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
CA2421976C (en) * 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
AU675633B2 (en) * 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
AU2008214205B2 (en) 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629985A (es) * 1962-11-29
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
JPS531814A (en) * 1976-06-28 1978-01-10 Toshiba Corp Control unit of induction motor
US4225597A (en) * 1976-10-01 1980-09-30 Schering Corporation Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom
IT1121513B (it) * 1979-05-28 1986-04-02 Chiesi Farma Spa Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol

Also Published As

Publication number Publication date
JPS5716820A (en) 1982-01-28
SU1184428A3 (ru) 1985-10-07
US4347236A (en) 1982-08-31
FR2482457A1 (fr) 1981-11-20
HU188093B (en) 1986-03-28
NL8102457A (nl) 1981-12-16
ES502286A0 (es) 1982-04-01
PL127872B1 (en) 1983-12-31
GB2076422A (en) 1981-12-02
CH647408A5 (de) 1985-01-31
DK218481A (da) 1981-11-20
CA1162852A (en) 1984-02-28
ES8203606A1 (es) 1982-04-01
PL231220A1 (es) 1982-01-18
ATA179181A (de) 1985-12-15
CS221831B2 (en) 1983-04-29
NO811686L (no) 1981-11-20
FI63672B (fi) 1983-04-29
NO155429C (no) 1987-04-01
FI63672C (fi) 1983-08-10
PT72989B (en) 1983-07-06
AT380791B (de) 1986-07-10
SE437766B (sv) 1985-03-18
BE888822A (fr) 1981-11-16
GB2076422B (en) 1983-12-14
FR2482457B1 (es) 1985-01-04
DE3119745A1 (de) 1982-02-11
NO155429B (no) 1986-12-22
SE8103143L (sv) 1981-11-20
FI801610A (fi) 1981-11-20
PT72989A (en) 1981-06-01

Similar Documents

Publication Publication Date Title
DD158856A5 (de) Verfahren fuer die herstellung einer mischung eines antiinflammotorischen steroids und eines als propellant verwendeten fluorchlor-kohlenwasserstoffes
DE2834308C2 (de) Verfahren zur Wasserabspaltung aus einer kolloidalen Liposomen-Dispersion
DE69233319T2 (de) Aerosolzusammensetzungen für Arzneimittelsuspensionen
DE69915144T2 (de) Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen
DE69920946T3 (de) Verfahren zur herstellung kristalliner partikel
DE2320111C2 (de) Beclomethasondipropionat, Betamethason-17-isobutyrat-21-acetat oder 21-Chlor-21-desoxybetamethason-17-propionat und deren Solvate mit einem Chlor- oder Chlorfluorkohlenwasserstoff mit 1 oder 2 Kohlenstoffatomen in einer besonderen kristallinen Form, Verfahren zu deren Herstellung und diese enthaltende Aerosolformulierungen
EP1809243B1 (de) Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
DE69735497T2 (de) Medizinische aerosolformulierungen enthaltend budesonid
DE2703119C2 (es)
CH652134A5 (de) Beclometasondipropionat-monohydrat von konstanter teilchengroesse und dieses enthaltende pharmazeutische zusammensetzung.
EP0504112A2 (de) Pharmazeutische Aerosolformulierungen
DE2624924C2 (de) Verfahren zur Herstellung einer neuen kristallinen Form von Flunisolid und diese enthaltende Aerosolzusammnesetzung
EP1307210B1 (de) Verfahren und vorrichtung zur anreicherung und stabilisierung von konjugierten oestrogenen aus stutenharn
DE60311665T2 (de) Pharmazeutische zusammensetzungen
DE2623682C3 (de) Verfahren zur Herstellung einer Sorbinsäure als feine Teilchen in hoher Konzentration enthaltenden wäßrigen Dispersion
DE3018550C2 (de) Verfahren zur umwandlung eines entzuendungshemmenden steroids in eine zur verabreichung mit aerosol geeignete form
DE1719443C3 (es)
EP0031454B1 (de) Fungizide Mischungen auf der Basis von Triforin und Carbendazim und Verfahren zu deren Herstellung
DE1617610C3 (de) Verfahren zum Herstellen eines Aerosol-Präparates für medizinische Zwecke
DE1148807B (de) Maleinsaeurehydrazidderivate enthaltende Mittel zur Regulierung, insbesondere Hemmung, des Pflanzenwachstums
DE3301306A1 (de) Steroid-monohydrate, verfahren zu ihrer herstellung und ihre verwendung
DE102012221219B4 (de) Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
DE2831419C2 (es)
DE2555408A1 (de) Emulsion einer perfluorierten verbindung in wasser
DD299211A7 (de) Verfahren zur herstellung einer aerosolformulierung